Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer. 

Biotechnology

Iovance Biotherapeutics

The Philadelphia office focuses on quality assurance, aseptic manufacturing, and compliance within the biopharmaceutical industry.

Philadelphia

Iovance Biotherapeutics' headquarters in San Carlos, CA, United States

The Philadelphia 2 office focuses on quality assurance, engineering, and manufacturing processes in the pharmaceutical sector.

Philadelphia 2

This department focuses on the production and processing of aseptic products, ensuring quality and safety in manufacturing operations.

Aseptic Manufacturing

This department oversees quality control, assurance processes, and compliance to ensure products and services meet established standards.

Quality Assurance

This department oversees clinical operations, regulatory compliance, and medical affairs to ensure the safe and effective development of pharmaceuticals.

Clinical and Regulatory Affairs

The Leadership Team at Iovance Biotherapeutics is responsible for guiding the strategic direction and operational oversight of the company as it develops innovative T cell-based therapies for cancer treatment. This diverse group of executives collaborates across various functions, including research, quality, operations, and commercial strategy, to ensure alignment with Iovance's mission of improving patient care and advancing cutting-edge cancer therapies. Through their collective expertise, the Leadership Team drives decision-making, fosters a culture of innovation, and builds partnerships essential for the company’s success in the biotherapeutics industry.

Leadership Team

This department oversees the entire manufacturing process, ensuring efficient production management and quality control.

Manufacturing Operations

This department oversees the management and coordination of cell therapy treatments and associated accounts.

��

People (37)

Jobs (0)

Other teams

Quality Assurance

Clinical and Regulatory Affairs

Leadership Team

Manufacturing Operations

Cell Therapy Operations

��������

People (37)

Jobs (0)

Other teams

Quality Assurance

Clinical and Regulatory Affairs

Leadership Team

Manufacturing Operations

Cell Therapy Operations

��